ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

Hanoi spurns China's vaccine diplomacy with homemade shot

Domestic drugmaker Nanogen seeks emergency approval as early as May

HANOI -- A Vietnamese pharmaceutical company has begun second phase trials on a coronavirus vaccine, an important step toward Hanoi's goal of vaccine independence from China amid rising territorial tensions between the countries.

If the trials are successful, Nanogen Pharmaceutical Biotechnology's Nano Covax vaccine is expected to be approved for emergency use as early as May. A quick rollout is crucial for Vietnam, which seeks to keep Beijing from exerting influence through its so-called vaccine diplomacy in Southeast Asia.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more